Navigation Links
Oncology Metrics and Cureline Announce Joint Marketing Agreement
Date:1/9/2008

ts looking to advance the treatment of cancer."

About Oncology Metrics

Oncology Metrics is a service and data business for the oncology community that develops products and services to help accelerate advancements in the treatment of cancer. Oncology Metrics has built three distinct networks of community-based oncology centers from which it gathers financial and operation information (Oncology Circle), clinical information (Data Direct), and biological specimens (Cure Pace). It accesses and aggregates this information to provide a platform of knowledge-based products and services. The cornerstone of Oncology Metrics' approach is to promote the discovery and adoption of best practice. Oncology Metric's customers include oncology care providers and all organizations involved in the quest to improve cancer diagnosis and treatment.

Oncology Metrics knowledge-based products and services will help providers improve their financial and clinical performance, industry develop better products and services for oncology professionals, and patients receive more effective individualized care.

The Oncology Metrics team is comprised of business and medical professionals with decades of experience in healthcare. Oncology Metrics was founded in 2001 and is based in Dallas-Fort Worth, Texas with an office in the San Francisco Bay Area.

Additional information about Oncology Metrics can be found at http://www.oncomet.com. Contact: Warren Dodge at 415-454-1338 or press@oncomet.com

About Cureline, Inc.

Cureline, Inc. is a global biosample management company providing effective solutions for scientifically challenging projects. The company was founded in 2003 by a group of scientists and business development professionals who established the biospecimen repository for SUGEN, Inc. and participated in the development of Sutent(R) (Pfizer Inc).

Cureline is dedicated to innovation in huma
'/>"/>

SOURCE Oncology Metrics
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related biology technology :

1. Center for Molecular Medicine Selected to Provide DNA Analysis for Childrens Oncology Group Leukemia Study
2. Quest PharmaTech to Receive $3,000,000 to Develop Oncology Products Based on its SonoLight Technology
3. AG Mednet to Provide Image Network for Southwest Oncology Group
4. IMPAC Medical Systems to Offer Revenue Cycle Inc.s Array of Oncology Products and Services to Customers
5. PRA International to Present Audioconference on Oncology Research - Nov. 8
6. Pharsight Invited to Present on Oncology Modeling and Simulation at Quantitative Pharmacology Symposium in China
7. Ranbaxy to Consolidate Position in Biopharmaceuticals and Speciality Injectables Including Oncology
8. Founder of ILEX Oncology and Triton Biosciences, Richard Love, Joins Board of Directors of Cell Therapeutics, Inc. (CTI)
9. Genstruct CEO, Dr. Keith Elliston, Invited to Speak at Oncology Clinical Trial Summit
10. Six UK Hospitals Join Together in Using Varian Medical Oncology Information Network
11. VivoMetrics(R) Appoints Howard R. Baker as New President and Chief Executive Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... -- Reportlinker.com announces that a new market ... ,, The Future of Orphan ... Pipeline Analysis and Reimbursement ,, ... Summary ,, The author has ... Orphan Diseases Therapeutics - Market Forecasts to ...
(Date:12/15/2009)... BRIARCLIFF MANOR, N.Y., Dec. 15 The ... announced that the professional society is continuing to ... is being held in Arlington, VA, April 19-21, ... society is encouraging non-members to join the organization ... event. The submission deadline is 12 AM EST, ...
(Date:12/15/2009)... Office has announced the launch of several innovative new ... services in the current economic climate. The first ... to finance legal services over a period of 6, ... in their start-up companies. The second is aimed ... payment arrangements over 6 to 12 month period at ...
(Date:12/14/2009)... third edition of Infusion Nursing: An ... the Infusion Nurses Society (INS), includes Totect(®), the ... are a group of chemotherapy medications including daunorubicin, ... in the treatment of various types of cancer ... to the INS publication: "In September 2007, the ...
Breaking Biology Technology:Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 2Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 3Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 4Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 5Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 6Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 7Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 8Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 9Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 10Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 11Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 12Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 13Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 14Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 15Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 16Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 17Reportlinker Adds The Future of Orphan Diseases Therapeutics - Market Forecasts to 2015, Pipeline Analysis and Reimbursement 18The International Society for Medical Publication Professionals Announces Call for Abstracts for Its 6th Annual Meeting 2The International Society for Medical Publication Professionals Announces Call for Abstracts for Its 6th Annual Meeting 3The Prinz Law Office Launches Innovative New Programs to Aid Cash-Strapped Entrepreneurs and Businesses 2Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 2Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 3Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 4Infusion Nurses Society References Totect(R) (Dexrazoxane For Injection) as the Only Antidote for the Treatment of Anthracycline Extravasation 5
... Inc. (OTC Bulletin Board: CSBR), a company engaged ... specific data to,enhance the value of oncology drugs, ... Under the terms of the private investment,Champions Biotechnology ... at $1.75 per share. There were no fees ...
... Company Taking ... Actions to Address New Challenges, KENILWORTH, N.J., April 23 ... for the first,quarter of 2008, reviewed progress on its ongoing ... addressed recent,events affecting the Merck/Schering-Plough cholesterol franchise., "The first ...
... Dutch researchers in Amsterdam have collaborated using for the ... Depression research. They used postmortem human brain tissue that ... purposes and investigated a region in the basal part ... be of crucial importance for the development of symptoms ...
Other Biology Technology:Champions Biotechnology, Inc. Completes $2,500,000 Private Financing at $1.75 per Share 2Champions Biotechnology, Inc. Completes $2,500,000 Private Financing at $1.75 per Share 3Schering-Plough Reports Financial Results for First Quarter of 2008 2Schering-Plough Reports Financial Results for First Quarter of 2008 3Schering-Plough Reports Financial Results for First Quarter of 2008 4Schering-Plough Reports Financial Results for First Quarter of 2008 5Schering-Plough Reports Financial Results for First Quarter of 2008 6Schering-Plough Reports Financial Results for First Quarter of 2008 7Schering-Plough Reports Financial Results for First Quarter of 2008 8Schering-Plough Reports Financial Results for First Quarter of 2008 9Schering-Plough Reports Financial Results for First Quarter of 2008 10Schering-Plough Reports Financial Results for First Quarter of 2008 11Schering-Plough Reports Financial Results for First Quarter of 2008 12Schering-Plough Reports Financial Results for First Quarter of 2008 13Schering-Plough Reports Financial Results for First Quarter of 2008 14Schering-Plough Reports Financial Results for First Quarter of 2008 15Schering-Plough Reports Financial Results for First Quarter of 2008 16Schering-Plough Reports Financial Results for First Quarter of 2008 17Schering-Plough Reports Financial Results for First Quarter of 2008 18Schering-Plough Reports Financial Results for First Quarter of 2008 19
(Date:12/14/2009)... Pa., Dec. 14 MODA Technology Partners, ... (EM), utility and product testing for the Pharmaceutical ... 3.0, the company,s third generation mobile data acquisition ... organizations to further automate their regulated manufacturing processes. ... capabilities: ,, Fully-Configurable Test Methods: ...
(Date:12/13/2009)... have identified plant enzymes that may help to engineer ... use water more efficiently. The finding could help to ... , Plants take in the carbon dioxide they need ... of leaves. But for each molecule of the gas ... same openings. The pores can tighten to save water ...
(Date:12/13/2009)... New Haven, Conn.A team led by Yale University ... in whole blood for the first time. Their ... online publication of Nature Nanotechnology , could ... of cancer and other diseases. , ... Professor of Engineering & Applied Science, and Tarek ...
Breaking Biology News(10 mins):MODA Announces Availability of Third Generation Mobile Data Acquisition Platform 2Newly identified enzymes help plants sense elevated CO2 and could lead to water-wise crops 2Newly identified enzymes help plants sense elevated CO2 and could lead to water-wise crops 3Scientists use nanosensors for first time to measure cancer biomarkers in blood 2Physicians Interactive Acquires Skyscape Inc Becoming Worlds Leading Mobile Medical Information Provider 52526 1Physicians Interactive Acquires Skyscape Inc Becoming Worlds Leading Mobile Medical Information Provider 52526 2Physicians Interactive Acquires Skyscape Inc Becoming Worlds Leading Mobile Medical Information Provider 52526 3Physicians Interactive Acquires Skyscape Inc Becoming Worlds Leading Mobile Medical Information Provider 52526 4Beta Blockers Tied to Higher Cataract Risk 52521 1Beta Blockers Tied to Higher Cataract Risk 52521 2Beta Blockers Tied to Higher Cataract Risk 52521 3Medifast Inc to Announce Second Quarter Fiscal Year 2009 Financial Results on Thursday July 30 2009 52517 1Medifast Inc to Announce Second Quarter Fiscal Year 2009 Financial Results on Thursday July 30 2009 52517 2
... Sea-viewing Wide Field-of-view Sensor (SeaWiFS) instrument settled into ... first measurements of ocean color. A decade later, ... applications and helped researchers paint a picture of ... anniversary today with briefings at the Goddard Space ...
... primates suggests that infants and children who carry a ... ill effects of fetal alcohol exposure. , Reported online ... the first evidence of a genetic risk for fetal ... by profound mental retardation in its most severe form, ...
... UT Southwestern Medical Center have found nearly 350 genes related ... much wider study in the poorly understood field of infertility. ... understand the causes of female infertility, said Dr. Diego Castrillon, ... appearing in the September issue of the journal Genetics ...
Other Biology News:NASA celebrates a decade observing climate impacts on health of world's oceans 2NASA celebrates a decade observing climate impacts on health of world's oceans 3Study reveals possible genetic risk for fetal alcohol disorders 2Study reveals possible genetic risk for fetal alcohol disorders 3UT Southwestern researchers identify hundreds of genes controlling female fertility 2
Each Yeast-GFP clone represents an individual S. cerevisiae strain containing an open reading frame with a C-terminal Aequorea Victoria GFP (S65T) fusion tag....
... forces with the Mickle Laboratory Engineering Company ... This tissue sectioning system has been designed ... experiments and to be especially applicable to ... or from small organs. Its special features ...
Without sodium bicarbonate. Sterile, Cell culture tested...
... The Bioactive peptides are molecules of peptidic ... behaviour or activity which can be developed ... chemical and agro-food applications. In this way ... with superior properties for therapeutic applications. Primm ...
Biology Products: